Zhejiang NHU Company Ltd.

SZSE:002001 Stock Report

Market Cap: CN¥52.0b

Zhejiang NHU Past Earnings Performance

Past criteria checks 2/6

Zhejiang NHU has been growing earnings at an average annual rate of 6.8%, while the Pharmaceuticals industry saw earnings growing at 10.6% annually. Revenues have been growing at an average rate of 17% per year. Zhejiang NHU's return on equity is 11.2%, and it has net margins of 18%.

Key information

6.8%

Earnings growth rate

6.6%

EPS growth rate

Pharmaceuticals Industry Growth10.9%
Revenue growth rate17.0%
Return on equity11.2%
Net Margin18.0%
Next Earnings Update23 Apr 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How Zhejiang NHU makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SZSE:002001 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2315,0362,710720890
30 Jun 2315,1372,890647835
31 Mar 2315,2383,060622821
31 Dec 2215,9343,620622859
30 Sep 2216,2133,975580863
30 Jun 2215,7924,143584871
31 Mar 2215,4354,415591851
01 Jan 2214,9174,356581783
30 Sep 2113,4554,020609716
30 Jun 2112,3513,782642678
31 Mar 2111,4803,808722612
31 Dec 2010,3143,564731546
30 Sep 209,3383,398731491
30 Jun 209,0743,221710462
31 Mar 208,4492,554651434
31 Dec 197,6602,165630435
30 Sep 197,7602,244570438
30 Jun 197,9212,173599432
31 Mar 197,4742,096597450
31 Dec 188,6833,079599457
30 Sep 188,8623,341620433
30 Jun 188,2783,177438553
31 Mar 188,0532,966477438
31 Dec 176,2351,704515336
30 Sep 175,3661,258518215
30 Jun 175,0021,2736850
31 Mar 174,8381,2796520
31 Dec 164,6961,2036240
30 Sep 164,4149625820
30 Jun 164,1947325760
31 Mar 163,9514775590
31 Dec 153,8234025480
30 Sep 153,9653805730
30 Jun 153,9654455610
31 Mar 154,1586855390
31 Dec 144,1648085220
30 Sep 144,3909845180
30 Jun 144,3501,0204980
31 Mar 144,1818964630
31 Dec 134,2388824400
30 Sep 133,7857003640
30 Jun 133,7757323620
31 Mar 133,7047773720

Quality Earnings: 002001 has high quality earnings.

Growing Profit Margin: 002001's current net profit margins (18%) are lower than last year (24.5%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 002001's earnings have grown by 6.8% per year over the past 5 years.

Accelerating Growth: 002001's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 002001 had negative earnings growth (-31.8%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (9.5%).


Return on Equity

High ROE: 002001's Return on Equity (11.2%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.